Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Akero Therapeutics Inc
About AKRO
Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, including metabolic dysfunction-associated steatohepatitis (MASH). Efruxifermin (EFX), its lead product candidate for MASH, is being evaluated in three ongoing Phase 3 studies: SYNCHRONY Outcomes in patients with compensated cirrhosis (F4) due to MASH, SYNCHRONY Histology in patients with pre-cirrhotic (F2-F3 fibrosis) MASH, and SYNCHRONY Real-World in patients with MASH (F1-F4). The Phase 3 SYNCHRONY program builds on the results of two Phase 2b clinical trials, the HARMONY study in patients with pre-cirrhotic MASH and the SYMMETRY study in patients with compensated cirrhosis due to MASH. EFX is an analog of fibroblast growth factor 21 (FGF21), which is an endogenously expressed hormone that protects against cellular stress and regulates metabolism of lipids, carbohydrates and proteins throughout the body.
Find out what a historical investment in Akero Therapeutics Inc would be worth today using our AKRO stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy AKRO shares in Australia?
Buying AKRO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Akero Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AKRO
What is the ticker symbol of Akero Therapeutics Inc?
The ticker symbol for Akero Therapeutics Inc is AKRO.
How much is one share of AKRO?
One share of AKRO is valued at $54.65 as of 20 May 2026.
What is the market capitalisation of Akero Therapeutics Inc AKRO?
As of 20 May 2026 Akero Therapeutics Inc has a market cap of -.
What is the 52-week high for Akero Therapeutics Inc stock?
The Akero Therapeutics Inc 52-week high stock price is $NaN.
What is the 52-week low for Akero Therapeutics Inc stock?
The Akero Therapeutics Inc 52-week low stock price is $NaN.
Can I buy AKRO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AKRO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKRO on Stake
- Buy AKRO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AKRO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AKRO related stocks